A genetic variant of the p22PHOX component of NADPH oxidase C242T is associated with reduced risk of functional dyspepsia in Helicobacter pylori-infected Japanese individuals

2009 ◽  
Vol 21 (12) ◽  
pp. 1363-1368 ◽  
Author(s):  
Tomomitsu Tahara ◽  
Tomoyuki Shibata ◽  
Fangyu Wang ◽  
Masakatsu Nakamura ◽  
Mikijyu Sakata ◽  
...  
2001 ◽  
Vol 36 (4) ◽  
pp. 351-355 ◽  
Author(s):  
R. J. L. F. Loffeld ◽  
B. F. M. Werdmuller ◽  
J. G. Kusters ◽  
E. J. Kuipers

2016 ◽  
Vol 53 (4) ◽  
pp. 1353-1363 ◽  
Author(s):  
Carl-Henrik Andersson ◽  
Oskar Hansson ◽  
Lennart Minthon ◽  
Niels Andreasen ◽  
Kaj Blennow ◽  
...  

1998 ◽  
Vol 13 (5) ◽  
pp. 500-504 ◽  
Author(s):  
CHING-LIANG LU ◽  
FULL-YOUNG CHANG ◽  
TSENG-SHING CHEN ◽  
CHIH-YEN CHEN ◽  
KANG LIH JIUN ◽  
...  

2006 ◽  
Vol 14 (7S_Part_31) ◽  
pp. P1648-P1649
Author(s):  
Sven J. Van der Lee ◽  
Iris E. Jansen ◽  
Olga Pletnikova ◽  
Cornelis Blauwendraat ◽  
Marc Hulsman ◽  
...  

2019 ◽  
Vol 9 (2) ◽  
pp. 321-324 ◽  
Author(s):  
Vahideh Ebrahimzadeh Attari ◽  
Mohammad Hosein Somi ◽  
Mohammad Asghari Jafarabadi ◽  
Alireza Ostadrahimi ◽  
Seyed-Yaghob Moaddab ◽  
...  

Purpose: The present study aimed to assess the effect of ginger (Zingiber officinale) powder supplementation on Helicobacter pylori eradication and improvement of dyspeptic symptoms in patients with H. pylori positive functional dyspepsia (FD). Methods: During this pilot study 15 patients with H. pylori positive FD received 3 g/d ginger powder as three 1-g tablets for 4-weeks. Dyspepsia symptoms were asked before and after the intervention using a questionnaire based on the Rome III criteria. H. pylori eradication was also assessed by a non-invasive stool antigen (HpSAg) test. Results: Ginger consumption accompanied by significant H. pylori eradication rate of 53.3% (P = 0.019) and the odds ratio (95% CI) was 8 (1.07 to 357.14). Moreover, our results showed significant changes in most of the dyspepsia symptoms after ginger supplementation. Conclusion: According to our findings, Z. officinale can be considered as a useful complementary therapy for FD. However, due to the small number of clinical trials in this area, further welldesigned clinical trials are needed to explicitly talk about its effectiveness especially about the eradication of H. pylori.


Gut ◽  
2002 ◽  
Vol 50 (Supplement 4) ◽  
pp. iv26-iv30 ◽  
Author(s):  
S J O Veldhuyzen van Zanten ◽  
N J Talley ◽  
A L Blum ◽  
E Bolling-Sternevald ◽  
M Sundin ◽  
...  

Antioxidants ◽  
2019 ◽  
Vol 8 (12) ◽  
pp. 637 ◽  
Author(s):  
Yongchae Park ◽  
Hanbit Lee ◽  
Joo Weon Lim ◽  
Hyeyoung Kim

Helicobacter pylori infection causes the hyper-proliferation of gastric epithelial cells that leads to the development of gastric cancer. Overexpression of tumor necrosis factor receptor associated factor (TRAF) is shown in gastric cancer cells. The dietary antioxidant β-carotene has been shown to counter hyper-proliferation in H. pylori-infected gastric epithelial cells. The present study was carried out to examine the β-carotene mechanism of action. We first showed that H. pylori infection decreases cellular IκBα levels while increasing cell viability, NADPH oxidase activity, reactive oxygen species production, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation, and TRAF1 and TRAF2 gene expression, as well as protein–protein interaction in gastric epithelial AGS cells. We then demonstrated that pretreatment of cells with β-carotene significantly attenuates these effects. Our findings support the proposal that β-carotene has anti-cancer activity by reducing NADPH oxidase-mediated production of ROS, NF-κB activation and NF-κB-regulated TRAF1 and TRAF2 gene expression, and hyper-proliferation in AGS cells. We suggest that the consumption of β-carotene-enriched foods could decrease the incidence of H. pylori-associated gastric disorders.


Sign in / Sign up

Export Citation Format

Share Document